|
Volumn 42, Issue 7, 2002, Pages 596-602
|
Central cholinergic challenging of migraine by testing second-generation anticholinesterase drugs
a b b b a |
Author keywords
Analgesia; Central cholinergic system; Cholinesterase inhibitor; Donepezil; Migraine; Primary pain; Prophylaxis
|
Indexed keywords
ANTIMIGRAINE AGENT;
CHOLINESTERASE INHIBITOR;
DONEPEZIL;
PROPRANOLOL;
SCOPOLAMINE;
ADULT;
ANIMAL BEHAVIOR;
ANTINOCICEPTION;
ANXIETY NEUROSIS;
ARTICLE;
ASTHENIA;
BRADYCARDIA;
CHOLINERGIC SYSTEM;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE SEVERITY;
DOSE TIME EFFECT RELATION;
DROWSINESS;
DRUG ANTAGONISM;
DRUG EFFECT;
DRUG EFFICACY;
DRUG SCREENING;
GENERAL PRACTICE;
HOT PLATE TEST;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MIGRAINE;
MOUSE;
NAUSEA;
NIGHTMARE;
NONHUMAN;
PAIN ASSESSMENT;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROPHYLAXIS;
REM SLEEP;
SELF ESTEEM;
SEXUAL DYSFUNCTION;
SIDE EFFECT;
SLEEP DISORDER;
SLEEP TIME;
VOMITING;
ADRENERGIC BETA-ANTAGONISTS;
ADULT;
ANALGESICS;
ANIMALS;
ANXIETY;
CENTRAL NERVOUS SYSTEM;
CHOLINESTERASE INHIBITORS;
FEMALE;
HUMANS;
INDANS;
MALE;
MICE;
MIGRAINE DISORDERS;
NAUSEA;
PIPERIDINES;
PROPRANOLOL;
SLEEP, REM;
TIME FACTORS;
TREATMENT OUTCOME;
VOMITING;
|
EID: 0036656622
PISSN: 00178748
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1526-4610.2002.02146.x Document Type: Article |
Times cited : (33)
|
References (18)
|